Here we continue our World Health Day top 6 innovations with the potential to improve human health countdown. If you missed part 1, you can find it here, where we kicked off our list with: (1) DNA Sequencing Technology; (2) Large Population-based Genetic Cohorts; and (3) DNA as a Storage Device. Prepare to be inspired as we continue with our final 3 topics below. Enjoy!Read More
DNA Genotek's Sample Collection Blog
I have to admit, coming up with the 9th edition of DNA Genotek's "Top 10 list" was much more difficult than I imagined it would be. There are so many great things that happened in the past year - in our company, with our customers, and in the fields of genetics, microbiome and infectious disease - but I think I've narrowed it down to those that are most significant. The list is by no means comprehensive, but these are the 10 things I'll remember most from 2017.Read More
Our excitement is growing as we quickly approach the American Society of Human Genetics (ASHG) meeting in Vancouver, Canada from Oct 18th – 22nd. With so many events scheduled, we understand the importance of early planning to get the most from attending the conference. This blog article highlights our events – and we hope you add one or many of them to your ASHG agenda.Read More
It is a new year and we are excited to share what changes we made as a result of your feedback in 2015. Your suggestions kept us busy, so let us take a few moments to present several highlights.Read More
Once again, it is time for our Customer Satisfaction Survey blog updates. To quickly recap, if you are new to our Customer Satisfaction Surveys, we send very brief post-purchase surveys (3 questions) to capture your suggestions and overall experience with us. Through this blog, we then share updates on actions we are taking based on your feedback. To read the previous related blog articles, use these links: (Customer feedback- are we listening? And DNA Genotek’s latest changes based on your feedback)Read More
So, you’ve just completed your latest human genomics research study and you’re waiting to hear if it has been accepted for publication. In the meantime, you’ve been exploring other hypotheses for health conditions and are interested in the growing field of microbiome and metagenomics research. According to a recent review, genetics explains ~20-50% of observed ‘heritability’ of medically important traits[i] but you’re interested in learning more about what makes up ‘the other 50%’. The dynamic microbiome is impacted by our daily activities and our environment (diet, exercise, sleep etc.) plays an important role in the etiology of chronic diseases not accounted for in GWAS. But there are a few items of interest that have delayed your decision to initiate a microbiome study. At the top of the list is how easy is it to integrate a microbiome study into your workflow? Is your lab set up to take on such a project? And what about the downstream applications and analysis. How different is it from SNP genotyping or whole genome sequencing? You also have to consider that you are used to working with saliva or blood and now you have to get familiar with a new sample type (and possibly an unpleasant one) – like feces. All these questions are getting into the ‘meat’ of things you consider when taking on your first microbiome project. But let’s back up a little and look at the big picture and find out why the microbiome is an interesting study area to pursue in the first place. Why all this fuss over some microbes?Read More
One of the most critical components of studying the microbiome is ensuring you have a profile that is representative of the microbial community present in the donor. The reality of microbiome research, and any research for that matter, is that a variety of factors can impact the quality of your sample and its microbial community and thus, the quality of your data. Assume for example, that the microbial profile resembles Diagram “A” when in the in vivo state. The goal is to minimize any potential source of variability so that your sample accurately reflects that of the in vivo state (Diagram B) rather than an “ex vivo” artefact (Diagram C). Think of it like this: you could take a “snapshot” of the microbial community at the time of collection, preserve it through the analysis and generate an accurate microbiome profile.